References Where the ALZET® Osmotic Pumps Were Used In Various Animal Models for Spinal Cord Injury Research

R0251 McKerracher,L., Higuchi,H. Targeting Rho to stimulate repair after spinal cord injury. Journal of Neurotrauma 2006; 23(-3-4-):309-317. >>> C3 transferase; Y-27632; CSF/CNS (intrathecal); Rat; ; Enzyme inhibitor (Rho kinase); review, see p. 313-314, ref. Fournier et al; Ramer et al; spinal cord injury.

P9186 White,R.E., Yin,F.Q., Jakeman,L.B. TGF-alpha increases astrocyte invasion and promotes axonal growth into the lesion following spinal cord injury in mice. Experimental Neurology 2008; 214(-1-):10-24. >>> Transforming growth factor-alpha; Serum, mouse; PBS; CSF/CNS (intrathecal); Mice; 2002; 14 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume; post op. care (Baytril); animal info (female, adult, C57BL/6, 10 wks old, 17-20 g.); spinal cord injury; pumps were primed in saline at 37 degree Celsius for 24 hours; pumps were weighed before and after filling; good methods.

P9177 Holmberg,E., Zhang,S.X., Sarmiere,P.D., Kluge,B.R., White,J.T., Doolen,S. Statins decrease chondroitin sulfate proteoglycan expression and acute astrocyte activation in central nervous system injury. Experimental Neurology 2008; 214(-1-):78-86. >>> Simvastatin; CSF/CNS; Rat; 2004; 4 weeks; Comparison of PO gavage vs. mp; ALZET brain infusion kit used; post op. care (buprenorphine); animal info (female, Long Evans, adult, 200-22 g.); cannula placement confirmed by preparing cryosections of the brain at the lateral ventricle and verifying the presence of a cavity created by the cannula; spinal cord injury.

P9168 Bao,F., Chen,Y.H., Schneider,K.A., Weaver,L.C. An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury. Experimental Neurology 2008; 214(-2-):160-167. >>> BIO5192; Tris lactose; IV (jugular); Rat; 2001D; 1 day; Controls received mp w/ vehicle; animal info (male, female, Wistar, 200-220 g.); incorrectly stated 1003D pump has 200 ul reservoir; pumps were primed in 37 degree Celsius saline for 4 hours; BIO5192 is an alpha4beta1 inhibitor; spinal cord injury; PE10 connected to silastic medical grade tubing.

P9167 Bretzner,F., Liu,J., Currie,E., Roskams,A.J., Tetzlaff,W. Undesired effects of a combinatorial treatment for spinal cord injury - transplantation of olfactory ensheathing cells and BDNF infusion to the red nucleus. European Journal of Neuroscience 2008; 28(-9-):1795-1807. >>> Brain-derived neurotrophic factor; PBS; CSF/CNS; Rat; 2002; 2 weeks; Controls received mp w/ vehicle; animal info (male, Sprague Dawley, adult, 300-400 g.); 28 gauge cannula, silastic tubing used; spinal cord injury; wound clips used.

P9132 Liu,S., Xu,G.Y., Johnson,K.M., Echetebu,C., Ye,Z.M., Hulsebosch,C.E., McAdoo,D.J. Regulation of interleukin-1beta by the interleukin-1 receptor antagonist in the glutamate-injured spinal cord: Endogenous neuroprotection. Brain Research 2008; 1231(-;-):63-74. >>> Interleukin-1, beta-, recomb.; interleukin-1, receptor antagonist; CSF, artificial; CSF/CNS (subarachnoid space); Rat; 1003D; 3 days; Controls received mp w/ vehicle; animal info (male, Sprague Dawley, 200-250 g.); spinal cord injury.

P9090 Wannier-Morino,P., Schmidlin,E., Freund,P., Belhaj-Saif,A., Bloch,J., Mir,A., Schwab,M.E., Rouiller,E.M., Wannier,T. Fate of rubrospinal neurons after unilateral section of the cervical spinal cord in adult macaque monkeys: Effects of an antibody treatment neutralizing Nogo-A. Brain Research 2008; 1217(-;-):96-109. >>> Immunoglobulin G, monoclonal, mouse; antibody, anti-Nogo-A monoclonal, human; anitbody, anti-Nogo-A monoclonal, mouse; CSF/CNS (intrathecal); Monkey; 2ML2; ; Control animals received mp w/ control antibodies; animal info (macaque, 3-8 years old); pumps replaced every 2 weeks; polyethylene tubing used; spinal cord injury.

P9079 Hurtado,A., Podinin,H., Oudega,M., Grimpe,B. Deoxyribozyme-mediated knockdown of xylosyltransferase-1 mRNA promotes axon growth in the adult rat spinal cord. Brain 2008; 131(-;-):2596-2605. >>> Deoxyribozyme, XT-1; CSF/CNS (spinal cord, intrathecal); Rat; 1007D; 14 days; Controls received mp w/ control deoxyribozyme or mp w/ saline; pumps replaced after 7 days; post op. care (gentamicin); animal info (female, Sprague Dawley, 200-225 g.); spinal cord injury; compound also known as DNAXTas; control also known as DNAXTmb; schematic w/ pump on fig. 1; custom cannula used.

P8873 Terayama,R., Omura,S., Fujisawa,N., Yamaai,T., Ichikawa,H., Sugimoto,T. Activation of microglia and p38 mitogen-activated protein kinase in the dorsal column nucleus contributes to tactile allodynia following peripheral nerve injury. Neuroscience 2008; 153(-4-):1245-1255. >>> SB203580; Saline; CSF/CNS (intrathecal, cisterna magna); Rat; 2002; 14 days; Controls received mp w/ vehicle; enzyme inhibitor (p38 MAP kinase); animal info (male, Sprague Dawley, 250-300g., spinal cord injury); PE10 tubing used; pump infusion schematic pg. 1246, Fig. 1.

P8706 Vavrek,R., Pearse,D.D., Fouad,K. Neuronal populations capable of regeneration following a combined treatment in rats with spinal cord transection. Journal of Neurotrauma 2007; 24(-10-):1667-1673. >>> Saline; CSF/CNS (intrathecal); Rat; 2002; 4 weeks; Animal info (female, Fischer, adult, spinal cord injury); chondroitinase ABC injected into IT catheter every other day for 4 weeks; saline mp used to keep catheters clear between injections.

P8458 Byrnes,K.R., Stoica,B.A., Fricke,S., Di Giovanni,S., Faden,A.I. Cell cycle activation contributes to post-mitotic cell death and secondary damage after spinal cord injury. Brain 2007; 130(--):2977-2992. >>> Flavopiridol; Saline; DMSO; CSF/CNS (intrathecal); Rat; 2001; 7 days; Controls received mp w/ vehicle; animal info (male, Sprague-Dawley, 275-325g); contusion spinal cord injury; 1% DMSO.

P7994 Vavrek,R., Girgis,J., Tetzlaff,W., Hebert,G.W., Fouad,K. BDNF promotes connections of corticospinal neurons onto spared descending interneurons in spinal cord injured rats. Brain 2006; 129(--):1534-1545. >>> Brain-derived neurotrophic factor; NT-3; Albumin, rat serum; CSF/CNS (left motor cortex, intrathecal, cisterna magna); Rat; 2002; 14 days; Controls received mp w/ vehicle; ALZET brain infusion kit used; SCI (spinal cord injury); dental cement used to secure cannula; NT-3 delivered intrathecally; tissue perfusion (left motor cortex).

P7808 Karimi-Abdolrezaee,S., Eftekharpour,E., Wang,J., Morshead,C.M., Fehlings,M.G. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. Journal of Neuroscience 2006; 26(-13-):3377-3389. >>> Fibroblast growth factor, basic; epidermal growth factor; platelet-derived growth factor-AA; CSF, artificial; gentamycin; BSA; CSF/CNS (intrathecal); Rat; 1007D; 7 days; Peptides; animal info (female, Wistar, 250g., spinal cord injury, neural precursor cells transplantation).

P7663 Kaplin,A.I., Deshpande,D.M., Scott,E., Krishnan,C., Carmen,J.S., Shats,I., Martinez,T., Drummond,J., Dike,S., Pletnikov,M., Keswani,S.C., Moran,T.H., Pardo,C.A., Calabresi,P.A., Kerr,D.A. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. Journal of Clinical Investigation 2005; 115(-10-):2731-2741. >>> Interleukin 6, recomb. rat; PBS; BSA; CSF/CNS (intrathecal, subarachnoid space); Rat; 1007D; 7 days; Controls received mp w/ vehicle; immunology; neurodegenerative (transverse myelitis, spinal cord injury); animal info (Sprague-Dawley, adult); SCI.

P7652 bdel-Karim,A.M., Barthlow,H.G., Bialecki,R.A., Elhilali,M.M. Effects of M274773 a neurokinin-2 receptor antagonist, on bladder function in chronically spinalized rats. Journal of Urology 2005; 174(-4-):1488-1492. >>> M274773; PEG 400; saline; SC; Rat; 2004; 1, 2 weeks; Animal info (female, Sprague-Dawley, 200-250 g); spinal cord injury (SCI).

P7563 Ikegami,T., Nakamura,M., Yamane,J., Katoh,H., Okada,S., Iwanami,A., Watanabe,K., Ishii,K., Kato,F., Fujita,H., Takahashi,T., Okano,H.J., Toyama,Y., Okano,H. Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury. European Journal of Neuroscience 2005; 22(-12-):3036-3046. >>> Chondroitinase ABC; Saline, physiological; CSF/CNS (intrathecal, subarachnoid space); Rat; 2001; 1 week; Controls received mp w/ heat inactivated agent; stability verified by ALZAID chemical compability test kit for 7 days; animal info (adult, female, Sprague-Dawley 230-250 g); mp primed overnight in 37 C saline; spinal cord injury.

P7265 Ji,B.X., Li,M.W., Budel,S., Pepinsky,R.B., Walus,L., Engber,T.M., Strittmatter,S.M., Relton,J.K. Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury. European Journal of Neuroscience 2005; 22(-3-):587-594. >>> Nogo-66 receptor (27-310) ecto-Fc; immunoglobulin G, rat; PBS; CSF/CNS (intrathecal); Rat; 2004; 28 days; Controls received mp w/ vehicle rat IgG; functionality of mp verified by residual volume; stability verified by analysis of remaining mp contents; post op. care (buprenorphine/buprenex, ampicillin); spinal cord injury.

P6902 Fouad,K., Schnell,L., Bunge,M.B., Schwab,M.E., Liebscher,T., Pearse,D.D. Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. Journal of Neuroscience 2005; 25(-5-):1169-1178. >>> Chondroitinase ABC; antibody, immunoglobulin G, recomb. mouse; galactosidase; Saline; PBS; CSF/CNS (intrathecal, lumbar); Rat; 2002; 4 weeks; Comparison of IT injections vs. mp; pumps replaced at two weeks; post op. care (antibiotic); spinal cord injury; Recathco catheter used; behavioral study.

P6803 Colpaert,F.C., Wu,W.P., Hao,J.X., Royer,I., Sautel,F., Wiesenfeld-Hallin,Z., Xu,X.J. High-efficacy 5-HT1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury. European Journal of Pharmacology 2004; 497(-1-):29-33. >>> F13640; SC; Rat; 2ML4; 56 days; Controls received mp w/ saline; functionality of mp verified by plasma levels; long-term study; pumps replaced at day 28; 5-HT1A receptor agonist; spinal cord injury; pain.

P6801 Iannotti,C., Zhang,Y.P., Shields,C.B., Han,Y.C., Burke,D.A., Xu,X.M. A neuroprotective role of glial cell line-derived neurotrophic factor following moderate spinal cord contusion injury. Experimental Neurology 2004; 189(-2-):317-332. >>> Glial-derived neurotrophic factor, recomb. human; glial-derived neurotrophic factor, alexa S94 dye-conjugated; Saline; CSF/CNS (intrathecal); Rat; 2004; 3 weeks; 28 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume and cannula patency; good methods p. 318; brain tissue distribution; spinal cord injury.

P6538 Grimpe,B., Silver,J. A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord. Journal of Neuroscience 2004; 24(-6-):1393-1397. >>> Oligodeoxyribonucleotide, phosphorothioated; CSF/CNS (intrathecal, subarachnoid space); Mice; 1007D; 7 days; Controls received mp w/ control DNA enzyme; antisense (xylosyltransferase-1); spinal cord injury; PE-60 tubing connected to PE-10 tubing for IT delivery; DNA enzyme against xylosyltransferase-1 (XT-1).

P6451 Seki,S., Sasaki,K., Igawa,Y., Nishizawa,O., Chancellor,M.B., De Groat,W.C., Yoshimura,N. Suppression of detrusor-sphincter dyssynergia by immunoneutralization of nerve growth factor in lumbosacral spinal cord in spinal cord injured rats. Journal of Urology 2004; 171(-1-):478-482. >>> Antibody, anti-nerve growth factor; CSF, artificial; CSF/CNS (intrathecal); Rat; 2002; 14 days; Controls received mp w/ vehicle; spinal cord injury; PE-10 used for catheterization.

P6347 Kim,D.H., Jahng,T.A. Continuous brain-derived neurotrophic factor (BDNF) infusion after methylprednisolone treatment in severe spinal cord injury. Journal of Korean Medical Science 2004; 19(-1-):113-122. >>> Brain-derived neurotrophic factor; CSF, artificial; CSF/CNS (intrathecal); Rat; 2004; 6 weeks; ALZET brain infusion kit; spinal cord injury; behavorial study.

P5597 Fournier,A.E., Takizawa,B.T., Strittmatter,S.M. Rho kinase inhibition enhances axonal regeneration in the injured CNS. Journal of Neuroscience 2003; 23(-4-):1416-1423. >>> C3 Transferase; Glutathione S-transferase; Y-27632; PBS; CSF/CNS (intrathecal); Rat; 2002; 2-3 weeks; Enzyme inhibitor (protein kinase); peptides; spinal cord injury; Y-27632 is a Rho-associated kinase (ROCK) inhibitor.

P4940 Jones,L.L., Tuszynski,M.H. Chronic intrathecal infusions after spinal cord injury cause scarring and compression. MICROSCOPY RESEARCH AND TECHNIQUE 2001; 54(--):317-324. >>> Dye, Evans Blue; Saline; CSF/CNS (intrathecal); Rat; 2002; 5 or 12 days; controls received mp w/ saline; functionality of mp verified by infusion of dye; pumps replaced after 5 of 12 days of infusion with fresh pumps filled with Evans Blue dye; dye infusion was for 2 days; catheter patency verified by infusion of Evans Blue dye; spinal cord injury; PE-10 was connected to PE-60 tubing..

P3678 Krenz,N.R., Meakin,S.O., Krassioukov,A.V., Weaver,L.C. Neutralizing intraspinal nerve growth factor blocks autonomic dysreflexia caused by spinal cord injury. J Neurosci 2003; 19(-17-):7405-7414. >>> Antibody, anti-nerve growth factor; Antibody, Immunoglobulin G; CSF, artificial; CSF/CNS (intrathecal); knee (articular cavity); Rat; 2ML2; 2 weeks; Controls received mp w/ vehicle; functionality of mp verified by residual volume; spinal cord injury; PE-10 intrathecal catheter tubing was perforated along its length and tip was sealed; PE-100 catheter used for knee joint infusion.

Looking for references? We can help!

ALZET will perform a custom bibliography search for you! ALZET pumps have been used to deliver hundreds of different compounds, including proteins and peptides, in a myriad of different experimental applications. We have recently updated our database, which now contains over 11,000 references that can help you guide your research project!

Request your ALZET bibliography search!

 

Order the ALZET SurgicalImplantation Video

Researchers are saying...

“In the majority of studies examining nicotine withdrawal, nicotine was delivered y an osmotic pump... The osmotic pump allows for the continuous delivery of nicotine at a controlled rate for a specified amount of time. An advantage of this delivery protocol is that nicotine levels in the bloodstream remain fairly constant, much like those of human chronic smokers. Discontinuing the delivery of nicotine by removal of the pump or interfering with nicotine’s effect on the central nervous system induces a withdrawal reaction... Accordingly, this experiment sought to replicate previous work using a rodent model of nicotine withdrawal developed by Malin et al. (1992) that has become widely used..., and which implements the osmotic pump as the nicotine delivery mechanism.” Besheer et al., Behavioral Neuroscience 2003;117(2):327-340.